Cargando…

Convalescent-anti-sars-cov-2-plasma/remdesivir: Sinus bradycardia, elevated ALT and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137424/ http://dx.doi.org/10.1007/s40278-021-96142-1

Ejemplares similares

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Sinus bradycardia and off label use in COVID-19 and :case report
Publicado: (2021)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia and lack of efficacy following off-label use: 4 case reports
Publicado: (2022)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/remdesivir: Treatment failure and off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Remdesivir: Elevated AST and ALT levels following off-label therapy: 4 case reports
Publicado: (2020)

Remdesivir: Sinus bradycardia: case report
Publicado: (2021)

Remdesivir: Sinus bradycardia: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia: case report
Publicado: (2021)

Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021)

Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia: 3 case reports
Publicado: (2021)

Remdesivir: Sinus bradycardia: 12 case reports
Publicado: (2022)

Remdesivir: Sinus bradycardia: 10 case reports
Publicado: (2022)

Convalescent-anti-sars-cov-2-plasma/remdesivir: Lack of efficacy during treatment of COVID-19 and off label use: 2 case reports
Publicado: (2022)

REMDESIVIR THERAPY AND ITS ASSOCIATION WITH SINUS BRADYCARDIA
por: ARSALAN ZAIDI, SYED, et al.
Publicado: (2021)

Summary Safety Review: sinus bradycardia with remdesivir
Publicado: (2021)

Remdesivir: Profound nocturnal sinus bradycardia: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/remdesivir/rituximab: COVID-19 infection, and lack of efficacy following off-label use: 20 case reports
Publicado: (2022)

REMDESIVIR-INDUCED EXTREME SINUS BRADYCARDIA IN COVID-19
por: Hamilton, Steven A., et al.
Publicado: (2022)

Remdesivir-Induced Marked Sinus Bradycardia in COVID-19
por: Ahmed, Taimoor, et al.
Publicado: (2022)

Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19
por: Wasef, Natale, et al.
Publicado: (2022)

Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection—reply
por: Mendez-Echevarria, Ana, et al.
Publicado: (2021)

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
por: Sanchez-Codez, Maria Isabel, et al.
Publicado: (2021)

Convalescent-anti-sars-cov-2-plasma/remdesivir: Lack of efficacy following: 2 case reports
Publicado: (2022)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Transfusion reaction during off-label therapy: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2022)

Remdesivir: Bradycardia: case report
Publicado: (2022)

Remdesivir: Bradycardia: case report
Publicado: (2022)

Remdesivir-associated bradycardia
por: Ching, Patrick R, et al.
Publicado: (2021)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022)

Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021)

Blinatumomab/convalescent-anti-SARS-CoV-2-plasma: B-cell depletion and off label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l37u8ptjqiiitd767aju2blftd